Related Experiment Video
Updated: Jun 29, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Severity of COVID-19 manifestations in HIV patients: a systematic review and meta-analysis
A Alam1, A A Soeroto, R A Susilohadi
1Infectious and Tropical Diseases Division, Department of Child Health, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, Indonesia. anggraini.alam@unpad.ac.id.
Insights
People living with HIV (PLWH) and HIV-negative individuals experienced similar COVID-19 rates and severity. Antiretroviral therapy (ART) is crucial for managing COVID-19 in PLWH, maintaining immunological health.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- The COVID-19 pandemic poses increased risks for people living with HIV (PLWH) due to potential immune compromise.
- Antiretroviral therapy (ART) may offer protective benefits against severe COVID-19 outcomes in PLWH.
Approach:
- A systematic review adhering to PRISMA guidelines was conducted, analyzing English-language articles from 2019-2022.
- Literature from PubMed, Science Direct, and Cochrane Library was screened for studies reporting HIV and COVID-19 case prevalence by severity.
- A random-effects model was employed to determine the pooled prevalence and severity of COVID-19 among PLWH.
Key Points:
- The study included 13 articles from an initial 1,965, analyzing COVID-19 prevalence and severity in PLWH.
- Pooled COVID-19 prevalence among PLWH was 3.0%, with critical, moderate, and mild severity rates of 4.8%, 24.4%, and 9.9%, respectively.
- Demographics showed a mean age of 52.98 years for PLWH with COVID-19, with 73% being male.
Conclusions:
- COVID-19 incidence and severity were comparable between PLWH and HIV-negative individuals.
- ART effectively supports immunological health in PLWH, comparable to immunocompetent individuals.
- ART plays a vital role in mitigating COVID-19 severity and mortality among PLWH.
Objective:
The incidence of coronavirus disease 2019 (COVID-19) pandemic among people living with HIV (PLWH) is experiencing major increases. This demographic is vulnerable due to compromised immune function, but the individuals are subjected to antiretroviral therapy (ART), which shows potential as a treatment for the pandemic. Therefore, this study aimed to investigate the severity of various forms of COVID-19 in PLWH as opposed to the general population.
Materials And Methods:
The study followed PRISMA guidelines and included a systematic review of literature from Pubmed, Science Direct, and Cochrane Library, comprising English-language articles from 2019 to 2022. This study included articles discussing HIV and COVID-19 case prevalence data by severity. A random effect model was used to demonstrate the pooled prevalence of COVID-19 among PLWH, as well as the prevalence of moderate and critical severity of COVID-19 among PLWH. The Joanna Briggs Institute checklist was used to assess the quality of studies. This study is registered in INPLASY No. INPLASY2023100063.
Results:
Out of a total of 1,965 articles relevant to the specified keyword combination, 13 articles conformed with inclusion and exclusion criteria. For HIV and non-HIV COVID-19 patients, the mean age was 52.98 ± 6.45 years and 55.84 ± 9.73 years, respectively. Approximately 73% of HIV COVID-19 patients were male. Symptoms among PLWH included fever (57%), cough (48.9%), and shortness of breath (37%). The pooled prevalence of COVID-19 among PLWH was 3.0% (95% CI, 1.0 - 8.5%), with critical, moderate, and mild severity in 4.8% (95% CI, 1.6 - 13.3%), 24.4% (95% CI, 1.9 - 29.8%), and 9.9% (95% CI, 1.9 - 38%), respectively.
Conclusions:
PLWHs and HIV-negative individuals showed comparable rates and intensity of COVID-19. ART users exhibited immunological health comparable to immunocompetent people, demonstrating the essential role of ART in reducing the severity and mortality of PLWH with COVID-19.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Sexually Transmitted Infections
Retrovirus Life Cycles
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

